Aamulya Apogee Therapeutics: Setting New Benchmarks in Atopic Dermatitis Apogee Therapeutics, Inc. (NASDAQ:APGE) reported Q4 earnings and provided pipeline updates today, inspiring a 30%-plus rally in its stock, breaching all-time highs. The company concentrates on developing biologics for conditions such as COPD and atopic dermatitis [AD]: "designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize ha ...